Sort   by:  
 Page size 
UnknownNovel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
Not available
S-EPMC3019678 | biostudies-literature
UnknownBoronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
Not available
S-EPMC4776006 | biostudies-literature
UnknownStructure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.
Not available
S-EPMC5981863 | biostudies-literature
UnknownInsights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.
Not available
S-EPMC8713471 | biostudies-literature
UnknownBiochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.
Not available
S-EPMC4263437 | biostudies-literature
UnknownBoronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses.
Not available
S-EPMC9872677 | biostudies-literature
TranscriptomicsRNA-seq of Colo-205 and RKO colon adenocarcinoma cell lines treated with Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazole Derivatives as Potential BRAFV600E Inhibitors and PLX4720
Two human colorectal adenocarcinoma cell lines (Colo-205 and RKO) were treated with PLX4720 and newly synthesized 2-Acetamido, 6-Carboxamide Substituted Benzothiazole Derivatives, as potential BRAF V600E inhibitors; IDK142, IDK145, IDK133 and DMSO as control.
ORGANISM(S): Homo sapiens 
2023-12-19 | E-MTAB-13097 | biostudies-arrayexpress
Sort   by:  
 Page size